Marisa Zallocchi

This study identifies quinoxaline derivatives that prevent noise-induced hearing loss by targeting early inflammatory signaling in zebrafish and mouse models.

This study compares gene expression in zebrafish and mouse inner ear hair cells to identify molecular differences underlying their physiological specializations.

This paper identifies EGFR inhibitors as potential therapeutics for noise-induced hearing loss using in silico transcriptome-based drug screening and experimental validation in zebrafish and mouse models.

The paper uses in silico transcriptomics to identify FDA-approved drugs and pathways that protect against cisplatin-induced hearing loss, validating niclosamide as a potential otoprotectant.